HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US Firm Removed From Warnings About Botanicals ‘Removed’ From Lawful Use In Supplements

Executive Summary

FDA retracts warning against Glanbia Performance Nutrition Manufacturing about selling adulterated dietary supplements.

You may also be interested in...



US FDA Warns About Botanicals Determined As Unlawful Being Used As Dietary Ingredients

One or more of 5-alpha-hydroxy laxogenin, higenamine, hordenine and octopamine is used by 11 firms FDA warned in products labeled as supplements and marketed as beneficial for weight loss and strength training.

US FDA Warns About Botanicals Determined As Unlawful Being Used As Dietary Ingredients

One or more of 5-alpha-hydroxy laxogenin, higenamine, hordenine and octopamine is used by 11 firms FDA warned in products labeled as supplements and marketed as beneficial for weight loss and strength training.

Dietary Ingredient Advisory List Yet To Fulfill Potential For US FDA

"We haven't utilized the ingredient advisory list quite as much as I'd like to see. But it's something we'll be working on this year,” says Cara Welch, acting director of FDA’s Office of Dietary Supplement Programs.

Topics

UsernamePublicRestriction

Register

RS152509

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel